Quick Answer
Vicapsys Life Sciences, Inc. reported Net Income of -$1.18 million for fiscal year 2023.
Vicapsys Life Sciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2023 | -$1.18M | -20.0% |
| 2022 | -$984.8K | -315.7% |
| 2021 | -$236.9K | +69.1% |
| 2020 | -$765.8K | +45.7% |
| 2019 | -$1.41M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | -$235.5K | +2.0% | -23.9% |
| June 30, 2024 | -$190.1K | -40.1% | +41.9% |
| March 31, 2024 | -$327.1K | -54.8% | -36.1% |
| September 30, 2023 | -$240.3K | -65.7% | -77.1% |
| June 30, 2023 | -$135.7K | +24.6% | +35.8% |
| March 31, 2023 | -$211.3K | -26.5% | -45.6% |
| September 30, 2022 | -$145.1K | -30.5% | +19.4% |
| June 30, 2022 | -$180.1K | -149.9% | -7.8% |
- Vicapsys Life Sciences, Inc. showed a decrease of -20.0% in Net Income compared to the prior fiscal year.
- Over the 2019–2023 period, Vicapsys Life Sciences, Inc.’s net income has grown by 16.1% (from -$1.41 million to -$1.18 million).
- The most recent figure is from Vicapsys Life Sciences, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on October 21, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: